27326810|t|International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension
27326810|a|Two distinct pulmonary vascular disorders, hepatopulmonary syndrome (HPS) and portopulmonary hypertension (POPH) may occur as a consequence of hepatic parenchymal or vascular abnormalities. HPS and POPH have major clinical implications for liver transplantation. A European Respiratory Society Task Force on Pulmonary-Hepatic Disorders convened in 2002 to standardize the diagnosis and guide management of these disorders. These International Liver Transplant Society diagnostic and management guidelines are based on that task force consensus and should continue to evolve as clinical experience dictates. Based on a review of over 1000 published HPS and POPH articles identified via a MEDLINE search (1985-2015), clinical guidelines were based on, selected single care reports, small series, registries, databases, and expert opinion. The paucity of randomized, controlled trials in either of these disorders was noted. Guidelines are presented in 5 parts; I. Definitions / Diagnostic criteria; II. Hepatopulmonary syndrome; III. Portopulmonary hypertension; IV. Implications for liver transplantation; and V. Suggestions for future clinical research.
27326810	0	58	International Liver Transplant Society Practice Guidelines	T170	C0162791
27326810	60	69	Diagnosis	T033	C0011900
27326810	74	84	Management	T058	C0376636
27326810	88	112	Hepatopulmonary Syndrome	T047	C0600452
27326810	117	144	Portopulmonary Hypertension	T047	C1868851
27326810	158	186	pulmonary vascular disorders	T047	C0854416
27326810	188	212	hepatopulmonary syndrome	T047	C0600452
27326810	214	217	HPS	T047	C0600452
27326810	223	250	portopulmonary hypertension	T047	C1868851
27326810	252	256	POPH	T047	C1868851
27326810	273	287	consequence of	T169	C0686907
27326810	288	307	hepatic parenchymal	T023	C0736268
27326810	311	333	vascular abnormalities	T033	C0241657
27326810	335	338	HPS	T047	C0600452
27326810	343	347	POPH	T047	C1868851
27326810	359	367	clinical	T080	C0205210
27326810	368	380	implications	T033	C0243095
27326810	385	406	liver transplantation	T061	C0023911
27326810	410	449	European Respiratory Society Task Force	T064	C0162458
27326810	453	480	Pulmonary-Hepatic Disorders	T047	C0012634
27326810	517	526	diagnosis	T033	C0011900
27326810	531	547	guide management	T170	C0162791
27326810	557	566	disorders	T047	C0012634
27326810	574	649	International Liver Transplant Society diagnostic and management guidelines	T170	C0162791
27326810	668	678	task force	T064	C0162458
27326810	722	730	clinical	T080	C0205210
27326810	793	796	HPS	T047	C0600452
27326810	801	805	POPH	T047	C1868851
27326810	832	846	MEDLINE search	T170	C0242356
27326810	860	879	clinical guidelines	T170	C0282451
27326810	895	923	selected single care reports	T058	C0700287
27326810	925	937	small series	T081	C0205549
27326810	939	949	registries	T170	C0034975
27326810	951	960	databases	T170	C0242356
27326810	966	980	expert opinion	T077	C0600219
27326810	997	1026	randomized, controlled trials	T062	C0206035
27326810	1046	1055	disorders	T047	C0012634
27326810	1067	1077	Guidelines	T170	C0282451
27326810	1107	1118	Definitions	T170	C0679227
27326810	1121	1140	Diagnostic criteria	T170	C0679228
27326810	1146	1170	Hepatopulmonary syndrome	T047	C0600452
27326810	1177	1204	Portopulmonary hypertension	T047	C1868851
27326810	1210	1222	Implications	T033	C0243095
27326810	1227	1248	liver transplantation	T061	C0023911
27326810	1257	1268	Suggestions	T078	C1705535
27326810	1280	1297	clinical research	T062	C0008972